United States · FDA National Drug Code directory
DELSTRIGO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-5007_246882d6-9ed0-452a-8da7-aa919a22b571
- Product NDC
- 0006-5007
- Form
- TABLET, FILM COATED
- Composition / generic term
- doravirine, lamivudine, and tenofovir disoproxil fumarate
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180720
- Source listing expiry
- 20271231
Source-listed ingredients
- DORAVIRINE — 100 mg/1
- LAMIVUDINE — 300 mg/1
- TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01) · 0006-5007-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →